TOFACITINIB
NDC 70069-841, TOFACITINIB, tablet, film coated, from Somerset Therapeutics, LLC.
- Product NDC
- 70069-841
- Status
- Listed
- Labeler
- Somerset Therapeutics, LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA220137
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70069-841 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOFACITINIB CITRATE5 mg/1
Pharmacologic classes
Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70069-841-01 | 70069084101 | 60 TABLET, FILM COATED in 1 BOTTLE (70069-841-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2726c2b0-c763-4635-ac6b-4334c3a5a8bcNADAC price for package 70069084101
GET /v1/drugs/nadac/70069084101
Use it
Look up 70069-841 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70069-841 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70069-841. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.